Machine learning identifies candidates for drug repurposing in Alzheimer's disease.
Academic Article
- Overview
- Identity
- Additional document info
- View All
Overview
publication date
- February 15, 2021
has subject area
- Alzheimer Disease
- Cerebral Cortex
- Drug Repositioning
- Drugs, Investigational
- Gene Expression Profiling
- Gene Expression Regulation
- High-Throughput Screening Assays
- Humans
- Machine Learning
- Nerve Tissue Proteins
- Neurons
- Neuroprotective Agents
- Nootropic Agents
- Pharmacogenetics
- Polypharmacology
- Prescription Drugs
- Primary Cell Culture
- Severity of Illness Index
published in
- Nature Communications Journal
- Nature communications Journal